Summit Therapeutics周一表示，英国制药商阿斯利康将向该公司投资20亿美元，并合作开展一系列研究，共同测试其癌症治疗方法。
Summit Therapeutics said on Monday that British drugmaker AstraZeneca would invest $2 billion in the company and collaborate on a series of studies testing their cancer treatments together.